Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab. (Q36402262)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab. |
scientific article |
Statements
Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab (English)
Christos Christodoulou
Vassiliki Kotoula
Ioannis Xanthakis
Anna Batistatou
George Pentheroudakis
Nikolaos Xiros
Irene Papaspirou
Pavlos Papakostas
Dimitrios Bafaloukos
Dimosthenis V Skarlos
Konstantine T Kalogeras
George Fountzilas
23 October 2012
23 October 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference